Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort

Table 3 Logistic regression analysis of the association of macular VD and Fazekas categories including adjusting factors

Variables	OR¹	95% CI¹	z¹	Significance¹
Age	1.14	1.04–1.26	2.75	0.006*
Sex	2.32	0.69–9.27	1.29	0.196
Syndromic diagnosis	0.41	0.10–1.51	1.29	0.197
Hypertension	6.35	1.94–23.61	2.94	0.003*
Diabetes mellitus	1.34	0.17–7.37	0.32	0.751
Dyslipidemia	0.37	0.10–1.22	1.56	0.118
Heart disease	0.77	0.08–4.61	0.26	0.794
Respiratory disease	4.29	0.82–22.30	1.77	0.077
Smoking	7.01	1.89–30.93	2.78	0.005*
VD nasal	1.03	0.84–1.27	0.30	0.762
VD temporal	1.18	0.93–1.54	1.33	0.182
VD superior	0.91	0.80–1.02	1.60	0.111
VD inferior	1.04	0.93–1.15	0.67	0.503

Including age, sex, syndromic diagnosis, hypertension, diabetes mellitus, dyslipidemia, heart disease, respiratory disease, and smoking as adjusting factors
Abbreviations: CI Confidence interval, OR Odds ratio, VD Vessel density
^*Significance was set up at p < 0.0125

ISSN: 1758-9193